DQ2 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

388 results for “DQ2”

Trials

View all 214 →

Clinical Relevance of Typing HLA-DR7-DQ2

92 participants · First posted Mar 19, 2013

HLA-DQ2-gliadin Tetramer for Diagnosis of Celiac Disease

100 participants · First posted Apr 8, 2010

Enrolling By Invitation

"Adding DNA-test for Screening of HLA-DQ2 and DQ8 to Improve Early Diagnosis of Celiac Disease"

508 participants · First posted Dec 21, 2023

Drugs

View all 55 →

HLA-DQ2/DQ8 inhibitors (Provid)

DQ2/8 Inhibitors(Provid pharmaceuticals)

HLA-DQ2 peptide vaccine (ImmusanT)

Organizations

DC2 Healthcare, LLC

United States

News

View all 118 →

Diamyd Immunotherapy Shows Robust Efficacy in Type 1 Diabetes Patients with HLA DR3-DQ2

Diamyd Immunotherapy Shows Robust Efficacy in Type 1 Diabetes Patients with HLA DR3-DQ2

Diamyd Demonstrates Robust Treatment Effects in Type 1 Diabetes Trials

Page 1 of 39